Trailing-twelve-month (TTM) revenue is $33.34 Million with a year-over-year growth of (6.90%). Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q4 FY2025Period ended 2025-09-30 | $8,500,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-12-03 |
| Q1 FY2026Period ended 2025-12-31 | $8,320,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-05 |
| Q2 FY2026Period ended 2026-03-31 | $8,132,999 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-06 |
| Q3 FY2026Period ended 2026-06-30 | $8,390,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-05 |
| TTM revenue | $33,342,999 |
Current P/S: $81,473,641 market capitalization ÷ $33,342,999 TTM revenue = 2.44x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T17:12:51.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q3 FY2026 (2026-06-30): $8.39M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T17:16:49.812Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-09-30 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-09-30 · USD | FY20212021-09-30 · USD | FY20222022-09-30 · USD | FY20232023-09-30 · USD | FY20242024-09-30 · USD | FY20252025-09-30 · USD |
|---|---|---|---|---|---|---|
| Investment Advice | $31M | $30M | $27M | $22M | $28M | $33M |
| Shareholder Service | $3M | $2M | $2M |
$33.34M
$33.34 Million
(6.90%)
vs. $35.81M a year ago (TTM)
+1.07%
5 Year compound annual growth rate
1 Year
(6.90%)
3 Year
+11.21%
5 Year
+1.07%
10 Year
(4.13%)
15 Year
+10.25%
20 Year
+3.66%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $35.54M | +$5.89M | +19.87% |
| 2024 | $29.65M | +$5.63M | +23.42% |
| 2023 | $24.02M | ($5.65M) | (19.03%) |
| 2022 | $29.67M | ($3.09M) | (9.44%) |
| 2021 | $32.76M | ($629,000) | (1.88%) |
| 2020 |
TTM Growth
(6.90%)
3-Year CAGR
+11.21%
5-Year CAGR
+1.07%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
| $2M |
| $2M |
| $33.39M |
| ($9.33M) |
| (21.83%) |
| 2019 | $42.72M | ($11.88M) | (21.75%) |
| 2018 | $54.59M | +$1.64M | +3.09% |
| 2017 | $52.95M | +$1.54M | +3.01% |
| 2016 | $51.41M | +$6.67M | +14.91% |
